koss-20220331x10q
false--06-30Q320220000056701YesYes0000056701us-gaap:CommonStockMember2021-07-012022-03-310000056701us-gaap:CommonStockMember2021-01-012021-03-310000056701us-gaap:CommonStockMember2020-07-012021-03-310000056701us-gaap:RetainedEarningsMember2022-03-310000056701us-gaap:AdditionalPaidInCapitalMember2022-03-310000056701us-gaap:RetainedEarningsMember2021-12-310000056701us-gaap:AdditionalPaidInCapitalMember2021-12-3100000567012021-12-310000056701us-gaap:RetainedEarningsMember2021-06-300000056701us-gaap:AdditionalPaidInCapitalMember2021-06-300000056701us-gaap:RetainedEarningsMember2021-03-310000056701us-gaap:AdditionalPaidInCapitalMember2021-03-310000056701us-gaap:RetainedEarningsMember2020-12-310000056701us-gaap:AdditionalPaidInCapitalMember2020-12-3100000567012020-12-310000056701us-gaap:RetainedEarningsMember2020-06-300000056701us-gaap:AdditionalPaidInCapitalMember2020-06-300000056701us-gaap:NonUsMember2022-01-012022-03-310000056701country:US2022-01-012022-03-310000056701us-gaap:NonUsMember2021-07-012022-03-310000056701country:US2021-07-012022-03-310000056701us-gaap:NonUsMember2021-01-012021-03-310000056701country:US2021-01-012021-03-310000056701us-gaap:NonUsMember2020-07-012021-03-310000056701country:US2020-07-012021-03-3100000567012021-07-012021-07-310000056701us-gaap:RetainedEarningsMember2022-01-012022-03-310000056701us-gaap:RetainedEarningsMember2021-07-012022-03-310000056701us-gaap:RetainedEarningsMember2021-01-012021-03-310000056701us-gaap:RetainedEarningsMember2020-07-012021-03-310000056701koss:CreditAgreementMemberkoss:TownBankMember2021-07-012022-03-310000056701us-gaap:RevolvingCreditFacilityMemberkoss:CreditAgreementMemberkoss:TownBankMember2022-03-310000056701us-gaap:LetterOfCreditMemberkoss:CreditAgreementMemberkoss:TownBankMember2022-03-310000056701koss:CreditAgreementMemberkoss:TownBankMember2022-03-310000056701koss:CreditAgreementMemberkoss:TownBankMember2021-06-300000056701koss:AdditionalRenewalMember2022-03-3100000567012021-07-012021-09-300000056701us-gaap:DomesticCountryMember2022-01-012022-03-310000056701us-gaap:StateAndLocalJurisdictionMember2021-07-012022-03-310000056701us-gaap:DomesticCountryMember2021-07-012022-03-310000056701us-gaap:DomesticCountryMember2021-01-012021-03-310000056701us-gaap:StateAndLocalJurisdictionMember2020-10-012020-12-310000056701us-gaap:DomesticCountryMember2020-07-012021-03-310000056701koss:CurrentOfficerSPlanMember2022-03-310000056701koss:FormerOfficerMember2021-06-300000056701koss:CurrentOfficerSPlanMember2021-06-300000056701koss:FormerOfficerMember2021-07-012021-12-310000056701koss:CurrentOfficerSPlanMember2021-10-012021-12-310000056701koss:CurrentOfficerSPlanMember2021-07-012022-03-310000056701koss:SbaLoanMember2022-03-310000056701us-gaap:RevolvingCreditFacilityMemberkoss:CreditAgreementMemberkoss:TownBankMemberus-gaap:LondonInterbankOfferedRateLIBORMember2021-07-012022-03-310000056701us-gaap:RevolvingCreditFacilityMemberkoss:AmendedCreditAgreementMemberkoss:TownBankMemberus-gaap:PrimeRateMember2021-07-012022-03-310000056701koss:Company2Memberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2021-07-012022-03-310000056701koss:Company1Memberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2021-07-012022-03-310000056701koss:Company2Memberus-gaap:TradeAccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2020-07-012021-06-300000056701koss:Company1Memberus-gaap:TradeAccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2020-07-012021-06-300000056701us-gaap:CommonStockMember2022-03-310000056701us-gaap:CommonStockMember2021-12-310000056701us-gaap:CommonStockMember2021-06-300000056701us-gaap:CommonStockMember2021-03-310000056701us-gaap:CommonStockMember2020-12-310000056701us-gaap:CommonStockMember2020-06-3000000567012021-03-3100000567012020-06-300000056701us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-3100000567012022-01-012022-03-310000056701us-gaap:AdditionalPaidInCapitalMember2021-07-012022-03-310000056701us-gaap:AdditionalPaidInCapitalMember2021-01-012021-03-3100000567012021-01-012021-03-310000056701us-gaap:AdditionalPaidInCapitalMember2020-07-012021-03-3100000567012020-07-012021-03-3100000567012022-03-3100000567012021-06-300000056701us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2021-07-012022-03-3100000567012021-12-012021-12-310000056701srt:MinimumMember2021-07-012022-03-310000056701srt:MaximumMember2021-07-012022-03-3100000567012022-05-0200000567012021-07-012022-03-31koss:itemxbrli:pureiso4217:USDxbrli:shareskoss:customeriso4217:USDxbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 10-Q

 

    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 for the quarterly period ended March 31, 2022

 

OR

 

    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 Commission File Number 0-3295

 

KOSS CORPORATION

(Exact Name of Registrant as Specified in its Charter)

 

DELAWARE

 

39-1168275

(State or other jurisdiction of

 

(I.R.S. Employer Identification No.)

incorporation or organization)

 

 

 

4129 North Port Washington Avenue, Milwaukee, Wisconsin

 

53212

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code: (414) 964-5000

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, par value $0.005 per share

KOSS

Nasdaq Capital Market

 

Indicate by check mark whether the registrant:  (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes   No 

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes   No 

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. 

 

Large accelerated filer 

 

Accelerated filer 

 

 

 

Non-accelerated filer 

 

Smaller reporting company 

 

 

 

 

Emerging growth company 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.).  Yes No

 

At May 2, 2022, there were 9,147,795 shares outstanding of the registrant’s common stock. 

  


KOSS CORPORATION

FORM 10-Q

March 31, 2022

 

INDEX

 

 

 

 

Page

 

 

 

PART I

FINANCIAL INFORMATION

3

 

Item 1.

Financial Statements (Unaudited)

3

 

 

Condensed Consolidated Balance Sheets as of March 31, 2022 and June 30, 2021

3

 

 

Condensed Consolidated Statements of Operations for the Three and Nine months Ended March 31, 2022 and 2021

4

 

 

Condensed Consolidated Statements of Cash Flows for the Nine Months Ended March 31, 2022 and 2021

5

 

 

Condensed Consolidated Statements of Stockholders’ Equity for the Three and Nine months Ended March 31, 2022 and 2021

6

 

 

Notes to Condensed Consolidated Financial Statements

7

 

Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

12

 

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

18

 

Item 4.

Controls and Procedures

18

PART II

OTHER INFORMATION

18

 

Item 1.

Legal Proceedings

18

Item 1A.

Risk Factors

18

 

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

18

 

Item 6.

Exhibits

20

 

2


PART I

FINANCIAL INFORMATION

Item 1.    Financial Statements

 

KOSS CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)

 

March 31, 2022

June 30, 2021

ASSETS

Current assets:

Cash and cash equivalents

$

9,487,935

$

6,950,215

Accounts receivable, less allowance for doubtful accounts of $6,284 and $41,500, respectively

2,316,329

2,240,785

Inventories, net

7,750,800

5,901,512

Prepaid expenses and other current assets

460,949

456,004

Total current assets

20,016,013

15,548,516

Equipment and leasehold improvements, net

1,146,222

1,281,180

Other assets:

Operating lease right-of-use asset

2,089,896

2,305,455

Cash surrender value of life insurance

5,704,776

7,188,994

Total other assets

7,794,672

9,494,449

Total assets

$

28,956,907

$

26,324,145

LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities:

Accounts payable

$

774,483

$

398,433

Accrued liabilities

806,544

665,567

Deferred revenue

595,984

694,632

Operating lease liability

298,291

288,949

Income taxes payable

4,380

4,543

Total current liabilities

2,479,682

2,052,124

Long-term liabilities:

Deferred compensation

2,284,909

2,491,482

Deferred revenue

170,440

188,932

Operating lease liability

1,791,605

2,016,506

Total long-term liabilities

4,246,954

4,696,920

Total liabilities

6,726,636

6,749,044

Stockholders' equity:

Common stock, $0.005 par value, authorized 20,000,000 shares; issued and outstanding 9,147,795 and 8,608,706, respectively

45,739

43,044

Paid in capital

12,571,779

10,802,118

Retained earnings

9,612,753

8,729,939

Total stockholders' equity

22,230,271

19,575,101

Total liabilities and stockholders' equity

$

28,956,907

$

26,324,145

 

 The accompanying notes are an integral part of these condensed consolidated financial statements. 

3


KOSS CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

 

Three Months Ended

Nine Months Ended

March 31

March 31

2022

2021

2022

2021

Net sales

$

4,634,552

$

3,987,452

$

13,415,506

$

14,125,537

Cost of goods sold

2,671,336

2,569,900

8,320,759

9,453,860

Gross profit

1,963,216

1,417,552

5,094,747

4,671,677

Selling, general and administrative expenses

1,566,430

2,271,615

4,576,521

5,393,211

Income (loss) from operations

396,786

(854,063)

518,226

(721,534)

Other income

6,415

378,805

362,389

885,505

Interest income

3,578

1,139

7,837

1,748

Income (loss) before income tax provision

406,779

(474,119)

888,452

165,719

Income tax provision

3,575

49

5,638

4,068

Net income (loss)

$

403,204

$

(474,168)

$

882,814

$

161,651

Income (loss) per common share:

Basic

$

0.04

$

(0.06)

$

0.10

$

0.02

Diluted

$

0.04

$

(0.06)

$

0.09

$

0.02

Weighted-average number of shares:

Basic

9,147,795

8,100,730

9,044,532

7,633,722

Diluted

9,888,083

8,100,730

10,024,473

9,188,002

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements. 

4


KOSS CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

 

Nine Months Ended

March 31

2022

2021

Operating activities:

Net income

$

882,814

$

161,651

Adjustments to reconcile net income to net cash (used in) provided by operating activities:

(Recovery of) provision for doubtful accounts of accounts receivable

(35,216)

(171)

Depreciation of equipment and leasehold improvements

225,130

222,998

Stock-based compensation expense

382,010

464,032

Change in cash surrender value of life insurance

(171,688)

(169,963)

Provision for deferred compensation

187,560

173,000

Deferred compensation paid

(71,250)

(112,500)

Deferred compensation relieved

(472,883)

Other income - SBA loan forgiveness

(506,700)

Other income - Net gain from life insurance benefits

(262,391)

Loss on disposal of fixed assets

7,856

Net changes in operating assets and liabilities:

Accounts receivable

(40,328)

355,531

Inventories

(1,849,288)

(1,318,377)

Prepaid expenses and other current assets

(4,945)

(212,482)

Income taxes payable

(163)

4,068

Accounts payable

376,050

122,598

Accrued liabilities

290,977

230,915

Deferred revenue

(117,140)

150,041

Net cash provided by operating activities

(672,895)

(435,359)

Investing activities:

Purchase of equipment and leasehold improvements

(98,028)

(546,664)

Life insurance premiums paid

(95,887)

(103,891)

Proceeds from life insurance policy

2,014,184

Net cash provided by (used in) investing activities

1,820,269

(650,555)

Financing activities:

Proceeds from exercise of stock options

1,390,346

3,115,457

Net cash provided by financing activities

1,390,346

3,115,457

Net increase in cash and cash equivalents

2,537,720

2,029,543

Cash and cash equivalents at beginning of period

6,950,215

3,999,409

Cash and cash equivalents at end of period

$

9,487,935

$

6,028,952

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements. 

5


KOSS CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (Unaudited)

 

Nine Months Ended March 31, 2022

Common Stock

Paid in

Retained

Shares

Amount

Capital

Earnings

Total

Balance, June 30, 2021

8,608,706

$

43,044

$

10,802,118

$

8,729,939

$

19,575,101

Net income

882,814

882,814

Stock-based compensation expense

382,010

382,010

Stock option exercises

539,089

2,695

1,387,651

1,390,346

Balance, March 31, 2022

9,147,795

$

45,739

$

12,571,779

$

9,612,753

$

22,230,271

Nine Months Ended March 31, 2021

Common Stock

Paid in

Retained

Shares

Amount

Capital

Earnings

Total

Balance, June 30, 2020

7,404,831

$

37,024

$

6,882,729

$

8,236,345

$

15,156,098

Net income

161,651

161,651

Stock-based compensation expense

464,032

464,032

Stock option exercises

1,111,992

5,560

3,109,897

3,115,457

Balance, March 31, 2021

8,516,823

$

42,584

$

10,456,658

$

8,397,996

$

18,897,238

Three Months Ended March 31, 2022

Common Stock

Paid in

Retained

Shares

Amount

Capital

Earnings

Total

Balance, December 31, 2021

9,147,795

$

45,739

$

12,452,554

$

9,209,549

$

21,707,842

Net income

403,204

403,204

Stock-based compensation expense

119,225

119,225

Stock option exercises

Balance, March 31, 2022

9,147,795

$

45,739

$

12,571,779

$

9,612,753

$

22,230,271

 

Three Months Ended March 31, 2021

Common Stock

Paid in

Retained

Shares

Amount

Capital

Earnings

Total

Balance, December 31, 2020

7,447,489

$

37,237

$

7,281,190

$

8,872,164

$

16,190,591

Net (loss)

(474,168)

(474,168)

Stock-based compensation expense

154,275

154,275

Stock option exercises

1,069,334

5,347

3,021,193

3,026,540

Balance, March 31, 2021

8,516,823

$

42,584

$

10,456,658

$

8,397,996

$

18,897,238

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

 

6


KOSS CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2022

(Unaudited)

 

1.    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

A)    BASIS OF PRESENTATION

 

The condensed consolidated balance sheets as of March 31, 2022 and June 30, 2021, the condensed consolidated statements of operations for the three and nine months ended March 31, 2022 and 2021, the condensed consolidated statements of cash flows for the nine months ended March 31, 2022 and 2021, and the condensed consolidated statements of stockholders' equity for the three and nine months ended March 31, 2022 and 2021, have been prepared by the Company in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) and have not been audited.  In the opinion of management, all adjustments (consisting of normal recurring adjustments) necessary to present fairly the financial position, results of operations and cash flows for all periods presented have been made.  The operating results for any interim period are not necessarily indicative of the operating results that may be experienced for the full fiscal year.

 

Certain information and footnote disclosure normally included in consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted.  These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2021.

 

The preparation of financial statements in conformity with U.S. GAAP requires the company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses. Significant estimates and assumptions are used for, but are not limited to, allowances for doubtful accounts, reserves for excess and obsolete inventories, long-lived and intangible assets, income tax valuation allowance, stock-based compensation and deferred compensation. Actual results could differ from the Company's estimates.

  

B)    INCOME TAXES

 

A state tax provision of $3,575 and $5,638 was recorded for the three and nine months ended March 31, 2022.  For the three and nine months ended March 31, 2021, the state tax provision was $49 and $4,068, respectively. The federal income tax expense was zero for the three and nine months ended March 31, 2022 and 2021.

In the nine months ended March 31, 2022, stock option exercises resulted in tax deductible compensation expense of approximately $8,000,000. The deduction of this stock option exercise compensation expense is expected to cause a tax loss in the year ended June 30, 2022, which will be carried forward to future tax years. The tax loss carryforward as of June 30, 2022, including the stock-based compensation expense deductions in the nine months ended March 31, 2022, is expected to be approximately $39,000,000. The adjustment to the estimated tax loss carryforward decreased the deferred tax asset to approximately $11,800,000 as of March 31, 2022, and the future realization of this is uncertain. The valuation allowance was also decreased to fully offset the deferred tax asset.

C) OTHER INCOME

In December 2021, the Company recognized approximately $262,000 of other income related to the proceeds from company-owned life insurance policies on its founder, who passed away on December 21, 2021.

In July 2021, the Company entered into a license agreement with a headphone manufacturer (whereby the manufacturer licensed the use of certain patents in certain of their headphones). The one-time license fee of $100,000 was also treated as other income. Other income is shown as a separate line on the condensed consolidated statements of operations. There was a related payment of $100,000 to a third party that was charged to legal expense in the first quarter.

D) DEFERRED COMPENSATION

The Company’s deferred compensation liabilities are for a current and former officer and are calculated based on various assumptions which may include compensation, years of service, expected retirement date, discount rates, and mortality tables. The related expense is calculated using the net present value of the expected payments and is included in selling, general and administrative expenses in the condensed consolidated statements of operations. The Company’s current and non-current compensation obligations are included in accrued liabilities and deferred compensation, respectively, in the condensed consolidated balance sheets.

7


In December 2021, the Company’s founder and former officer passed away. The Company had a total deferred compensation liability of $472,883 recorded at June 30, 2021 related to the former officer, which at his death was relieved. Deferred compensation income of $472,883 was recognized in selling, general and administrative expenses as a result. Payments of $71,250 were made under this arrangement until December 31, 2021 and were expensed as paid. The remaining deferred compensation liability of $2,284,909 and $2,168,599 recorded at March 31, 2022 and June 30, 2021, respectively, relates to a current officer’s plan. Deferred compensation expense of $20,000 and $116,310 was recognized under this arrangement in the three and nine months ended March 31, 2022.

 

 

2.    INVENTORIES

 

The components of inventories were as follows:

 

March 31, 2022

June 30, 2021

Raw materials

$

2,240,057

$

2,067,572

Finished goods

7,395,266

5,621,228

Inventories, gross

9,635,323

7,688,800

Reserve for obsolete inventory

(1,884,523)

(1,787,288)

Inventories, net

$

7,750,800

$

5,901,512

3.    CREDIT FACILITY AND SBA LOAN

 

On May 14, 2019, the Company entered into a secured credit facility ("Credit Agreement") with Town Bank (“Lender”). The Credit Agreement provides for a $5,000,000 revolving secured credit facility with an interest rate of 1.50% over LIBOR. The Credit Agreement also provides for letters of credit for the benefit of the Company of up to a sublimit of $1,000,000. There are no unused line fees in the credit facility. On January 28, 2021, the Credit Agreement was amended to extend the expiration to October 31, 2022, and to change the interest rate to Wall Street Journal Prime less 1.50%. The Company and the Lender also entered into a General Business Security Agreement dated May 14, 2019 under which the Company granted the Lender a security interest in substantially all of the Company’s assets in connection with the Company’s obligations under the Credit Agreement. The Credit Agreement contains certain affirmative and negative covenants customary for financings of this type. The negative covenants include restrictions on other indebtedness, liens, fundamental changes, certain investments, disposition of assets, mergers and liquidations, among other restrictions. As of March 31, 2022, the Company was in material compliance with all covenants related to the Credit Agreement. As of March 31, 2022, and June 30, 2021, there were no outstanding borrowings on the facility. 

On April 13, 2020, the Company received an unsecured loan (the "SBA Loan") for $506,700 under the Small Business Administration ("SBA") Paycheck Protection Program (the “PPP”) of the CARES Act through Town Bank. On November 3, 2020, the Company was notified that the full principal amount of $506,700 had been forgiven and was recorded as other income in the accompanying condensed statement of operations for the nine months ended March 31, 2021.

  


8


4.    REVENUE RECOGNITION

 

The Company disaggregates its net sales by geographical location as it believes it best depicts how the nature, timing and uncertainty of net sales and cash flows are affected by economic factors. The following table summarizes net sales by geographical location:

 

Three Months Ended

Nine Months Ended

March 31,

March 31,

2022

2021

2022

2021

United States

$

3,735,235

$

2,693,041

$

9,781,357

$

10,291,957

Export

899,317

1,294,411

3,634,149

3,833,580

Net Sales

$

4,634,552

$

3,987,452

$

13,415,506

$

14,125,537

Deferred revenue relates primarily to consumer and customer warranties. These constitute future performance obligations, and the Company defers revenue related to these future performance obligations. In the nine months ended March 31, 2022 and 2021, the Company recognized revenue, which was included in the deferred revenue liability at the beginning of the periods, of $394,963 and $271,179 respectively, for performance obligations related to consumer and customer warranties.  The deferred revenue liability was $593,920 as of June 30, 2020. The Company estimates that the deferred revenue performance obligations are satisfied within one year to three years and therefore uses that same time frame for recognition of the deferred revenue.

  

5.    INCOME (LOSS) PER COMMON AND COMMON STOCK EQUIVALENT SHARE

 

Basic income (loss) per share is computed based on the weighted-average number of common shares outstanding.  Diluted income (loss) per common share is calculated assuming the exercise of stock options except where the result would be anti-dilutive.  The following table reconciles the numerator and denominator used to calculate basic and diluted income (loss) per share:

Three Months Ended March 31,

Nine Months Ended March 31,

2022

2021

2022

2021

Numerator

Net income (loss)

$

403,204

$

(474,168)

$

882,814

$

161,651

Denominator

Weighted average shares, basic

9,147,795

8,100,730

9,044,532

7,633,722

Dilutive effect of stock compensation awards (1)

740,288

979,941

1,554,280

Diluted shares

9,888,083

8,100,730

10,024,473

9,188,002

Net income (loss) attributable to common shareholders per share:

Basic

$

0.04

$

(0.06)

$

0.10

$

0.02

Diluted

$

0.04

$

(0.06)

$

0.09

$

0.02

 

(1) Excludes approximately 2,226,184 weighted average stock options during the three months ended March 31, 2021, as the impact of such awards was anti-dilutive. For the three and nine months ended March 31, 2022, and the nine months ended March 31, 2021, no stock options were anti-dilutive.

  

6.    RELATED PARTY LEASE

 

The Company leases its facility in Milwaukee, Wisconsin from Koss Holdings, LLC, which is wholly owned by the Company’s former Chairman’s revocable trust.  On January 5, 2017, the lease was renewed for a period of five years, ending June 30, 2023, and is being accounted for as an operating lease.  The lease extension maintained the rent at a fixed rate of $380,000 per year and included an option to renew at the same rate for an additional five years ending June 30, 2028.  The Company is responsible for all property maintenance, insurance, taxes and other normal expenses related to ownership.

7.    ACCOUNTS RECEIVABLE CONCENTRATIONS

 

As of March 31, 2022, the Company’s top two accounts receivable customers represented approximately 28% and 18% of trade accounts receivables. These same customers represented approximately 24% and 19% of trade accounts receivable at June 30, 2021.

9


8.    LEGAL MATTERS

 

As of March 31, 2022, the Company is involved in the matters described below:

In July 2020, the Company filed complaints in United States District Court against each of Apple Inc., Bose Corporation, PEAG, LLC d/b/a JLab Audio, Plantronics, Inc. and Polycom, Inc., and Skullcandy, Inc. The complaints allege infringement on the Company’s patents relating to its wireless audio technology. In the event that a monetary award or judgment is received by the Company in connection with these complaints, all or portions of such amounts will be due to third parties. The Company does not expect to incur additional fees and costs related to these lawsuits that will have a material impact to its financial statements. Depending on the response to and the underlying results of the enforcement program, the Company may continue to litigate its claims, enter into licensing arrangements or reach some other outcome potentially advantageous to its competitive position.

A trial date for the suit against Apple Inc. in the U.S. District Court in the Western District of Texas is currently set for July 25, 2022.

• Early in fiscal year 2020, the Company was notified by One E-Way, Inc. that some of the Company's wireless products may infringe on certain One E-Way patents. No lawsuits involving these allegations have yet been filed and served on the Company.

The ultimate resolution of these matters is not determinable unless otherwise noted. We also are subject to a variety of other claims and suits that arise from time to time in the ordinary course of our business. Although management currently believes that resolving these claims against us, individually or in aggregate, will not have a material adverse impact on our condensed consolidated financial statements, these matters are subject to inherent uncertainties and management’s view of these matters may change in the future.


10


CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

 

This Form 10-Q contains forward-looking statements within the meaning of that term in the Private Securities Litigation Reform Act of 1995 (the “Act”) (Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934).  Additional written or oral forward-looking statements may be made by the Company from time to time in filings with the Securities Exchange Commission, press releases, or otherwise.  Statements contained in this Form 10-Q that are not historical facts are forward-looking statements made pursuant to the safe harbor provisions of the Act.  Forward-looking statements may include, but are not limited to, projections of revenue, income or loss and capital expenditures, statements regarding future operations, anticipated financing needs, compliance with financial covenants in loan agreements, plans for acquisitions or sales of assets or businesses, plans relating to products or services of the Company, assessments of materiality, predictions of future events, the effects of pending and possible litigation and assumptions relating to the foregoing.  In addition, when used in this Form 10-Q, the words “aims,” “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “thinks,” “may,” “will,” “shall,” “should,” “could,” “would,” “forecasts,” “predicts,” “potential,” “continue” and variations thereof and similar expressions are intended to identify forward-looking statements.

 

Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified based on current expectations.  Consequently, future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements contained in this Form 10-Q, or in other Company filings, press releases, or otherwise.  In addition to the factors discussed in this Form 10-Q, other factors that could contribute to or cause such differences include, but are not limited to, developments in any one or more of the following areas: future fluctuations in economic conditions, the receptivity of consumers to new consumer electronics technologies, the rate and consumer acceptance of new product introductions, competition, pricing, the number and nature of customers and their product orders, production by third party vendors, foreign manufacturing, sourcing, and sales (including foreign government regulation, trade and importation concerns),  the effects of the COVID-19 pandemic on the economy, the impact of the Russian-Ukrainian conflict and the Company’s operations, borrowing costs, changes in tax rates, pending or threatened litigation and investigations, and other risk factors described in the Risk Factors and in Management’s Discussion and Analysis of Financial Condition and Results of Operations sections of the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2021 and subsequently filed Quarterly Reports on Form 10-Q 

Readers are cautioned not to place undue reliance on any forward-looking statements contained herein, which speak only as of the date hereof.  The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect new information.

 

 

11


 Item 2.    Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

Overview

 

The Company developed stereo headphones in 1958 and has been recognized as a leader in the industry ever since. Koss markets a complete line of high-fidelity headphones, wireless Bluetooth® headphones, wireless Bluetooth® speakers, computer headsets, telecommunications headsets, and active noise canceling headphones. The Company operates as one business segment, as its principal business line is the design, manufacture and sale of stereo headphones and related accessories.

Financial Results

 

The following table presents selected financial data for the three and nine months ended March 31, 2022, and 2021:

Three Months Ended

Nine Months Ended

March 31

March 31

Financial Performance Summary

2022

2021

2022

2021

Net sales

$

4,634,552

$

3,987,452

$

13,415,506

$

14,125,537

Net sales increase (decrease) %

16.2%

(16.7)%

(5.0)%

(1.7)%

Gross profit

$

1,963,216

$

1,417,552

$

5,094,747

$

4,671,677

Gross profit as % of net sales

42.4%

35.6%

38.0%

33.1%

Selling, general and administrative expenses

$

1,566,430

$

2,271,615

$

4,576,521

$

5,393,211

Selling, general and administrative expenses as % of net sales

33.8%

57.0%

34.1%

38.2%

Interest income

$

3,578

$

1,139

$

7,837

$

1,748

Other income

$

6,415

$

378,805

$

362,389

$

885,505

Income (loss) before income tax provision

$

406,779

$

(474,119)

$

888,452

$

165,719

Income (loss) before income tax as % of net sales

8.8%

(11.9)%

6.6%

1.2%

Income tax provision

$

3,575

$

49

$

5,638

$

4,068

Income tax provision as % of income (loss) before income tax

0.9%

(0.0)%

0.6%

2.5%

  


12


2022 Results Compared with 2021

(comments refer to both the three and nine month periods ended March 31 unless otherwise noted)

 

Net sales for the quarter ended March 31, 2022 increased 16.2% behind better than expected direct-to-consumer (DTC) sales and sales to our distributor market class. For the nine months ended March 31, 2022, net sales declined by 5% driven primarily by declines in sales to certain of our distributors and minimal sales to mass retailers.

 

Net sales in the domestic market were approximately $3,735,000 in the three months ended March 31, 2022, compared to approximately $2,693,000 in the prior year period. Domestic net sales for the nine months ended March 31, 2022 were $9,781,000 compared to $10,292,000 for the same period in the prior year, a decrease of 5%. Net sales to our largest distributor were down as a result of a prior year surge in demand for communication headsets in the education market that did not continue at the same level in the current fiscal period. Also, the loss of sales to a mass retailer in the U.S. for a non-Koss branded product impacted sales by $188,000 and $1,080,000 for the three and nine months ended March 31, 2022, respectively. The final shipment of this product was during the quarter ended March 31, 2021. These net sales were at lower than average margins. These declines were mostly offset by growth in DTC sales.

 

Export net sales decreased to approximately $899,000 for the three months ended March 31, 2022, compared to approximately $1,294,000 for the same period last year due to an overall reduction in sales to Europe distributors. Export net sales for the nine months ended March 31, 2022 also declined, to approximately $3,634,000 in the current fiscal year as compared to approximately $3,834,000 in the prior year period. The continuing decline in sales to distributors in Asia was the primary driver for the nine month decrease.

 

Gross profit increased to 38.0% for the nine months ended March 31, 2022, compared to 33.1% for the nine months ended March 31, 2021.  Sales in the current year continue to reflect a more favorable mix in both markets and products. Increased, higher margin sales to DTC and the distributors class translated to higher gross profit margins. Lost placement at a U.S. based mass retailer, which was low margin business, contributed as well.

The delays throughout the supply chain that began late last fiscal year as a result of the persistence of COVID-19 in all parts of the world, and presently due in part to the recent conflict in Eastern Europe, continue to affect the Company. Chinese New Year added to the delays in product shipments from suppliers in Asia. The ongoing disruption in ocean freight and congestion at the ports on the U.S. west coast resulting in delivery delays have resulted in increased inbound shipping costs. While rising shipping costs are expected to linger and negatively impact margins in the foreseeable future, the Company did see lower freight rates on inbound shipments during the quarter ended March 31, 2022, due in part to a dedicated freight forwarding partner.

 

Selling, general and administrative expenses for the three months ended March 31, 2022 decreased 31.0%, or approximately $705,000, to approximately $1,566,000.  The decrease was primarily driven by a drop in employer taxes on stock option exercises which were approximately $536,000 during the prior year’s third quarter and zero in the current quarter. For the nine months ended March 31, 2022, selling, general and administrative expenses dropped $817,000, or 15.1%, compared to the same period in the prior year. The primary factors were the reversal of the deferred compensation liability of $473,000 for the Company’s founder who passed away in December 2021 and lower employer taxes on fewer stock option exercises during the nine months ended March 31, 2022.

Other income for the three and nine months ended March 31, 2022 was $6,000 and $362,000, respectively, compared to $379,000 and $886,000 during the same three and nine month periods in the prior year. In fiscal year 2022, the Company recognized $262,000 of other income related to the proceeds from a company-owned life insurance policy on its founder, who passed away in December 2021. Also, in July 2021, the Company recorded a one-time license fee of $100,000 related to a license agreement entered into with a headphone manufacturer whereby the manufacturer licensed the use of certain patents in certain of their headphones. A related payment of $100,000 to a third party was charged to legal expense. For the nine months ended March 31, 2021, other income includes $507,000 related to the forgiveness of the Company’s unsecured loan under the Small Business Administration Paycheck Protection Program of the CARES Act as well as $379,000 received from a director in disgorgement of short-swing profits under Section 16(b) of the Exchange Act.

.

Income tax expense for the three and nine months ended March 31, 2022 was comprised of the U.S. federal statutory rate of 21% and the blended state income tax rate of approximately 3.5%, offset by an adjustment to the valuation allowance for deferred tax assets. The effective tax rate was less than 1% in the three and nine months ended March 31, 2022 and 2021. It is anticipated that the effective rate in the current year and future years will be reduced by utilization of a portion or all of the federal net operating loss carryforwards that existed as of June 30, 2021, plus the additional federal net operating loss carryforward generated by the deductible compensation expense on stock option exercises for the nine months ended March 31, 2022.

 


13


In the nine months ended March 31, 2022, stock option exercises resulted in tax deductible compensation expense of approximately $8,000,000. The deduction of this stock option exercise compensation expense will cause a tax loss in the year ended June 30, 2022, which will be carried forward to future tax years. The expected federal tax loss carryforward, including the stock-based compensation expense deductions in the nine months ended March 31, 2022, will be approximately $39,000,000. The quarterly adjustment to the estimated tax loss carryforward decreased the deferred tax asset to approximately $11,800,000 as of March 31, 2022, and the future realization of this is uncertain. The valuation allowance was also decreased to fully offset the deferred tax asset.

As previously reported, the Company maintains a program focused on enforcing its intellectual property and, in particular, certain of its patent portfolio. The Company has enforced its intellectual property by filing complaints against certain parties alleging infringement on the Company’s patents relating to its wireless headphone technology. If the program is successful, the Company may receive royalties, offers to purchase its intellectual property, or other remedies advantageous to its competitive position; however, there is no guarantee of a positive outcome from these efforts, which could ultimately be time consuming and unsuccessful. Additionally, in the event that a monetary award or judgment is received by the Company in connection with these complaints, all or portions of such amounts will be due to third parties.

The Company believes that its financial position remains strong. The Company had $9.5 million of cash and cash equivalents and available credit facilities of $5.0 million on March 31, 2022. 


14


Recent Events

Recent events continuing to impact our business include COVID-19, the inflationary cost environment, disruption in our supply chain, and Russia’s invasion of Ukraine. As more fully described below, we expect each of these factors will impact our fiscal 2022 performance.

While the impact of these factors remains uncertain, we will continue to evaluate the extent to which these factors will impact our business, financial condition, or results of operations. These and other uncertainties with respect to these recent events could result in changes to our current expectations.

COVID-19: The Company has closely monitored the impact of COVID-19 (including the emergence of variants) to protect the health and safety of its employees and customers.  Business plans are being continuously updated and executed to maintain supply of the Company’s products to our customers throughout the world. While we expect the impacts of COVID-19 on our business to moderate, there still remains uncertainty around the pandemic. As a result of the COVID-19 pandemic, uncertainty with respect to its economic effects has impacted not only our operating results but also the global economy. The extent and nature of government actions to ease restrictions are varied based upon the current extent and severity of the COVID-19 pandemic within their respective countries and localities. The Company saw a surge in the sale of specific communication headsets in the nine months ended March 31, 2021 that did not repeat in the same period in the current year. Also, certain retail businesses throughout the Company’s markets, particularly in certain European markets due to the spread of the Omicron subvariant BA.2, have seen continued disruption.  The Company expects the negative sales impacts caused by this disruption to continue until markets more fully re-open and consumer spending returns to normal. 

The ultimate magnitude of the COVID-19 pandemic, including the extent of its impact on the Company’s business, financial position, results of operations or liquidity, cannot be reasonably estimated at this time due to the rapid development and fluidity of the situation. The Company's future results will be determined by the effectiveness of vaccines, rollout of vaccine boosters, the duration of the pandemic, impact of variants, its geographic spread, further business disruptions and the overall impact on the economy throughout the globe.

To protect the safety, health and well-being of employees, customers, and suppliers, the Company continues to maintain several preventive measures while also meeting the needs of global customers. They include increased frequency of cleaning and disinfecting of facilities, social distancing practices, remote working when possible, restrictions on business travel, holding certain events virtually and limitations on visitor access to facilities.

The Company is committed to continuing to execute these plans and will remain in close contact with its supply chain to monitor future possible implications, especially on production facilities.

Inflationary Cost Environment and Supply Chain Disruption – During fiscal 2022, we have experienced inflationary cost increases in our commodities, packaging materials and transportation costs. These increases have been partially mitigated by pricing actions implemented in the third quarter of the current fiscal year, as well as working with a dedicated freight forwarding partner to minimize freight rate increases.

The Company’s supply chain is primarily in southern China.  Since late fiscal year 2021, the Company has experienced issues related to the availability of containers and routings to move products in a cost effective and time efficient manner. There have also been impacts to the movement of new product introductions and costs. The Company is monitoring the situation closely and the supply chain team has modified business plans, which include, but are not limited to: (1) increasing the investment in inventory; (2) being alert to potential short supply situations; (3) assisting suppliers with acquisition of critical components; and (4) utilizing alternative sources and/or air freight.  The latest COVID-19 resurgence resulted in another shut-down of several major ports in China, thus impacting manufacturing of our products and shipments from our suppliers.

Russia’s Invasion of Ukraine: The invasion of Ukraine by Russia and the sanctions imposed in response to this conflict have increased global economic and political uncertainty. In accordance with the recent Executive Order declared on April 6, 2022, the Company has suspended sales into Russia. Also, given the current humanitarian crisis in Ukraine and the population seeking refuge in other countries, sales to Ukraine have been impacted. Neither Russia nor Ukraine constitutes a significant portion of the business, less than 5% of net sales for the three months ended March 31, 2022, so there was not a material impact on the current quarter. We are uncertain, however, of the impact it will have on our results of operations for the future.

 

15


Liquidity and Capital Resources

 

Cash Flows

 

The following table summarizes cash flows from operating, investing and financing activities for the nine months ended March 31, 2022 and 2021:

 

Total cash provided by (used in):

2022

2021

Operating activities

$

(672,895)

$

(435,359)

Investing activities

1,820,269

(650,555)

Financing activities

1,390,346

3,115,457

Net increase in cash and cash equivalents

$

2,537,720

$

2,029,543

 

Operating Activities

 

The investment in inventories was the driving factor for the increase in cash used by operating activities during the nine months ended March 31, 2022.  The Company increased the investment in inventory to ensure availability and to provide better inventory positions on key products to mitigate the continued impacts of supply chain disruptions. The impact of the investment in inventory was partially offset by increased accounts payable and accrued liabilities related to the inventory investment and an increase in customer deposits from certain of our export customers. The cash used by operating activities in the nine months ended March 31, 2022 also included a net gain of $262,000 on a life insurance policy held on the Company’s founder, who passed away in December 2021.

 

Investing Activities

 

Cash provided by investing activities for the nine months ended March 31, 2022 was related to the receipt of $2,014,000 of proceeds on company-owned life insurance policies on the Company’s founder who passed away in December 2021. This was slightly offset by premiums paid for company-owned life insurance policies on other executives. In the prior year, the Company had increased expenditures for a new operating system and leasehold improvements. The Company expects to generate sufficient cash flow from operations or from the use of its available cash and its credit facility to fund any necessary tooling, leasehold improvement and capital expenditures.

 

Financing Activities

 

In the nine months ended March 31, 2022, an aggregate of 539,089 shares of common stock were issued as a result of employee stock option exercises under the Company’s 2012 Omnibus Incentive Plan. The cash provided from these stock option exercises was approximately $1,390,000. An aggregate of 1,111,992 shares of common stock were issued as a result of employee stock option exercises under the Company’s 2012 Omnibus Incentive Plan in the nine months ended March 31, 2021. The cash provided from these stock option exercises was approximately $3,115,000.

As of March 31, 2022, the Company had no outstanding borrowings on its bank line of credit facility. 

 

There were no purchases of common stock in the quarters ended March 31, 2022 or 2021 under the stock repurchase program. 

Liquidity

 

The Company's capital expenditures are primarily for leasehold improvements and tooling. In addition, it has interest payments on its borrowings when it uses its line of credit facility. The Company believes that cash generated from operations, together with cash reserves and available borrowings, provide it with adequate liquidity to meet operating requirements, debt service requirements and planned capital expenditures for the next twelve months following the date of this Quarterly Report on Form 10-Q and thereafter for the foreseeable future. The Company regularly evaluates new product offerings, inventory levels and capital expenditures to ensure that it is effectively allocating resources in line with current market conditions.


16


Credit Facility

 

On May 14, 2019, the Company entered into a secured credit facility ("Credit Agreement") with Town Bank (“Lender”). The Credit Agreement provides for a $5,000,000 revolving secured credit facility with an interest rate of 1.50% over LIBOR. The Credit Agreement also provides for letters of credit for the benefit of the Company of up to a sublimit of $1,000,000. There are no unused line fees in the credit facility. On January 28, 2021, the Credit Agreement was amended to extend the expiration to October 31, 2022, and to change the interest rate to Wall Street Journal Prime less 1.50%. The Company and the Lender also entered into a General Business Security Agreement dated May 14, 2019 under which the Company granted the Lender a security interest in substantially all of the Company’s assets in connection with the Company’s obligations under the Credit Agreement. The Credit Agreement contains certain affirmative and negative covenants customary for financings of this type. The negative covenants include restrictions on other indebtedness, liens, fundamental changes, certain investments, disposition of assets, mergers and liquidations, among other restrictions. As of March 31, 2022, the Company was in material compliance with all covenants related to the Credit Agreement. As of March 31, 2022, and June 30, 2021, there were no outstanding borrowings on the facility. 

Contractual Obligation

 

The Company leases its facility in Milwaukee, Wisconsin from Koss Holdings, LLC, which is wholly owned by the Company’s former Chairman’s revocable trust.  On January 5, 2017, the lease was renewed for a period of five years, ending June 30, 2023, and is being accounted for as an operating lease.  The lease extension maintained the rent at a fixed rate of $380,000 per year and included an option to renew at the same rate for an additional five years ending June 30, 2028.  The Company is responsible for all property maintenance, insurance, taxes and other normal expenses related to ownership.

  

Off-Balance Sheet Transactions

 

At March 31, 2022, the Company did not have any transactions, obligations or relationships that could be considered off-balance sheet arrangements.


17


Item 3.    Quantitative and Qualitative Disclosures About Market Risk

 

Not applicable. 

  

Item 4.    Controls and Procedures

 

Disclosure Controls and Procedures

 

Disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e)) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) are designed to ensure that: (1) information required to be disclosed in reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms; and (2)  such information is accumulated and communicated to management, including the principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosures.  There are inherent limitations to the effectiveness of any system of disclosure controls and procedures, including the possibility of human error and the circumvention or overriding of controls and procedures.  Accordingly, even effective disclosure controls and procedures can only provide reasonable assurance of achieving their control objectives.

 

The Company’s management, including the Company’s Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the design and operation of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of March 31, 2022.  The Company’s Chief Executive Officer and Chief Financial Officer have concluded that the Company’s disclosure controls and procedures as of March 31, 2022 were effective.

 

Changes in Internal Control Over Financial Reporting

 

There have been no changes in the Company’s internal control over financial reporting (as defined in Exchange Act Rules 13a–15(f) and 15d–15(f)) that occurred during the Company’s most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

  

PART II

OTHER INFORMATION

  

Item 1.    Legal Proceedings

From time-to-time, we may be involved in litigation relating to claims arising out of our operations in the normal course of business. During the period covered by this report, there were no material changes to the description of legal proceedings set forth in Part I, Item 3 of our Annual Report on Form 10-K for the fiscal year ended June 30, 2021.  

 

Item 1A.    Risk Factors

In addition to the other information set forth in this report, you should carefully consider the factors discussed below and under Part 1. Item 1A, “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended June 30, 2021, as filed with the Securities and Exchange Commission on August 20, 2021. These factors could materially adversely affect our business, financial condition, liquidity, results of operations and capital position, and could cause our actual results to differ materially from our historical results or the results contemplated by any forward-looking statements contained in this report. There have been no material changes to the risk factors described under “Risk Factors,” included in our Annual Report on Form 10-K for the fiscal year ended June 30, 2021.   

Item 2.    Unregistered Sales of Equity Securities and Use of Proceeds

 

The following table presents information with respect to purchases of common stock of the Company made during the three months ended March 31, 2022, by the Company.


18


COMPANY REPURCHASES OF EQUITY SECURITIES

 

Total # of
Shares
Purchased

Average
Price Paid
per Share

Total Number of Shares Purchased as
Part of Publicly Announced Plan (1)

Approximate Dollar Value of
Shares Available under Repurchase Plan

January 1 - March 31, 2022

$

$

2,139,753

 

(1)In April of 1995, the Board of Directors approved a stock repurchase program authorizing the Company to purchase from time to time up to $2,000,000 of its common stock for its own account. Subsequently, the Board of Directors periodically has approved increases in the stock repurchase program. The most recent increase was for an additional $2,000,000 in October 2006, for a maximum of $45,500,000 of which $43,360,247 had been expended through March 31, 2022.  


19


 

Item 6.    Exhibits

Exhibit No.

Exhibit Description

3.1

Amended and Restated Certificate of Incorporation of Koss Corporation, as in effect on November 19, 2009. Filed as Exhibit 3.1 to the Company’s Quarterly Report on Form 10-Q for the period ended December 31, 2009 and incorporated herein by reference.

3.2

By-Laws of Koss Corporation. Filed as Exhibit 3.2 to the Company’s Annual Report on Form 10-K for the year ended June 30, 1996 and incorporated herein by reference.

3.3

Amendment to the By-Laws of Koss Corporation. Filed as Exhibit 3.3 to the Company’s Current Report on Form 8-K on March 7, 2006 and incorporated herein by reference.

3.4

Amendment to the By-Laws of Koss Corporation. Filed as Exhibit 3.4 to the Company’s Annual Report on Form 10-K on August 27, 2020 and incorporated herein by reference.

31.1

Rule 13a-14(a)/15d-14(a) Certification of Chief Executive Officer *

31.2

Rule 13a-14(a)/15d-14(a) Certification of Chief Financial Officer *

32.1

Section 1350 Certification of Chief Executive Officer **

32.2

Section 1350 Certification of Chief Financial Officer **

101

The following financial information from Koss Corporation's Quarterly Report on Form 10-Q for the quarter ended March 31, 2022, formatted in XBRL (eXtensible Business Reporting Language): (i) Condensed Consolidated Balance Sheets as of March 31, 2022 and June 30, 2021, (ii) Condensed Consolidated Statements of Operations (Unaudited) for the three and nine months ended March 31, 2022 and 2021 (iii) Condensed Consolidated Statements of Cash Flows (Unaudited) for the nine months ended March 31, 2022 and 2021, (iv) Condensed Consolidated Statements of Stockholders' Equity (Unaudited) for the three and nine months ended March 31, 2022 and 2021 and (v) the Notes to Condensed Consolidated Financial Statements (Unaudited). *

__________________________

*    Filed herewith

**  Furnished herewith

 

20


SIGNATURES

 

Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

KOSS CORPORATION

 

 

 

/s/ Michael J. Koss

May 6, 2022

Michael J. Koss

 

Chairman

 

Chief Executive Officer

 

 

 

/s/ Kim M. Schulte

May 6, 2022

Kim M. Schulte

 

Chief Financial Officer

 

Principal Accounting Officer

 

  

21

Exhibit 311

Exhibit 31.1

 

Certification of Chief Executive Officer 

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

I, Michael J. Koss, certify that:

1.

I have reviewed this quarterly report on Form 10-Q of Koss Corporation;

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the condensed financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.

I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)    designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its subsidiary, is made known to me by others within those entities, particularly during the period in which this report is being prepared;

b)    designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)    evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)    disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.

I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a)    All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b)    Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.



 

Dated: May 6, 2022

 

 

 

/s/ Michael J. Koss

 

Michael J. Koss

 

Chairman and Chief Executive Officer

 




Exhibit 312

Exhibit 31.2

 

Certification of Chief Financial Officer 

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

I, Kim M. Schulte, certify that:

1.

I have reviewed this quarterly report on Form 10-Q of Koss Corporation;

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the condensed financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.

I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)    designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its subsidiary, is made known to me by others within those entities, particularly during the period in which this report is being prepared;

b)    designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)    evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)    disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.

I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a)    All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b)    Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

 

Dated: May 6, 2022

 

 

 

/s/ Kim M. Schulte

 

Kim M. Schulte

 

Chief Financial Officer

 




Exhibit 321

Exhibit 32.1

 

Certification of Chief Executive Officer

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,

18 U.S.C. Section 1350

 

I, Michael J. Koss, Chief Executive Officer of Koss Corporation (the “Company”), hereby certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350 that to my knowledge:

 

(i)

the Quarterly Report on Form 10-Q of the Company for the quarter ended March  31, 2022 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

(ii)

the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



 

  

/s/ Michael J. Koss

 

Michael J. Koss

 

Chairman and Chief Executive Officer

 

Dated: May 6, 2022

 

Note:  This certification accompanies the Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed, except to the extent required by the Sarbanes-Oxley Act of 2002, by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

 


Exhibit 322

Exhibit 32.2

 

Certification of Chief Financial Officer

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 

18 U.S.C. Section 1350

 

I, Kim M. Schulte, Chief Financial Officer of Koss Corporation (the “Company”), hereby certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350 that to my knowledge:

 

(i)

the Quarterly Report on Form 10-Q of the Company for the quarter ended March  31, 2022 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

(ii)

the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



 

 

/s/ Kim M. Schulte

 

Kim M. Schulte

 

Chief Financial Officer

 

Dated: May 6, 2022

 

Note:  This certification accompanies the Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed, except to the extent required by the Sarbanes-Oxley Act of 2002, by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.